MDxHealth SA Stock Euronext Bruxelles
Stocks
MDXH
BE0974461940
Biotechnology & Medical Research
| Market Cap | 21.39M 24.45M 19.73M 18.22M 34.57M 2.33B 35.15M 236M 92.56M 1.15B 91.8M 89.8M 3.95B | P/E 2026 * |
-0.74x | P/E 2027 * | -1.05x |
|---|---|---|---|---|---|
| Enterprise Value | 143M 164M 132M 122M 232M 15.63B 236M 1.58B 620M 7.7B 615M 602M 26.47B | EV / Sales 2026 * |
1.5x | EV / Sales 2027 * | 1.5x |
| Free-Float |
88.87% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: MDxHealth SA
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 64 | 2019-02-17 | |
Ron Kalfus
DFI | Director of Finance/CFO | 52 | 2019-07-21 |
Miriam Reyes
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Hilde Windels
BRD | Director/Board Member | 61 | 2017-10-31 |
Koen Hoffman
CHM | Chairman | 58 | 2017-12-31 |
| Director/Board Member | 64 | 2019-02-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -2.58% | - | - | 24.45M | |
| +0.58% | +2.06% | +3.90% | +10.40% | 50.73B | |
| -2.22% | -1.25% | +391.53% | +591.38% | 39.73B | |
| -0.54% | +0.39% | +27.67% | -3.89% | 34.69B | |
| -1.36% | +0.35% | +19.34% | +58.83% | 33.21B | |
| +1.21% | -4.58% | +3.00% | +37.03% | 26.76B | |
| -1.81% | -1.48% | - | - | 16.8B | |
| +0.51% | -3.47% | +66.38% | +125.61% | 15.37B | |
| +0.23% | -0.58% | +13.80% | +19.56% | 13.78B | |
| -0.62% | -3.09% | +11.43% | -29.93% | 12.85B | |
| Average | -0.40% | -0.83% | +67.13% | +101.12% | 27.1B | |
| Weighted average by Cap. | -0.48% | -0.23% | +82.75% | +126.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 95.51M 109M 88.1M 81.37M 154M 10.41B 157M 1.05B 413M 5.13B 410M 401M 17.64B | 107M 123M 99.14M 91.57M 174M 11.72B 177M 1.18B 465M 5.77B 461M 451M 19.85B |
| Net income | -27.85M -31.84M -25.69M -23.73M -45.02M -3.04B -45.78M -307M -121M -1.5B -120M -117M -5.14B | -17.95M -20.52M -16.56M -15.29M -29.01M -1.96B -29.5M -198M -77.68M -964M -77.05M -75.37M -3.31B |
| Net Debt | 122M 139M 113M 104M 197M 13.3B 200M 1.34B 528M 6.55B 524M 512M 22.52B | 140M 160M 129M 119M 226M 15.28B 230M 1.54B 606M 7.53B 601M 588M 25.87B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
